AstraZeneca (Brazil)

1.2k papers and 52.1k indexed citations i.

About

In recent decades, authors affiliated with AstraZeneca (Brazil) have published 1.2k papers, which have received a total of 52.1k indexed citations. Scholars at this organization have produced 263 papers in Molecular Biology, 213 papers in Pulmonary and Respiratory Medicine and 206 papers in Oncology on the topics of Asthma and respiratory diseases (71 papers), Lung Cancer Treatments and Mutations (63 papers) and Gastroesophageal reflux and treatments (53 papers). Their work is cited by papers focused on Molecular Biology (12.1k citations), Oncology (11.7k citations) and Pulmonary and Respiratory Medicine (11.3k citations). Authors at AstraZeneca (Brazil) collaborate with scholars in Brazil, United States and United Kingdom and have published in prestigious journals including Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences. Some of AstraZeneca (Brazil)'s most productive authors include Lars Lind, Trung N. Tran, Jeremy S. Parker, David R. Spring and Anderson J. Ryan.

In The Last Decade

Fields of papers published by authors at AstraZeneca (Brazil)

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers affiliated with AstraZeneca (Brazil) at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.

Countries citing scholars working at AstraZeneca (Brazil)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at AstraZeneca (Brazil). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at AstraZeneca (Brazil) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AstraZeneca (Brazil) more than expected).

Rankless by CCL
2025